New horizons in the pathogenesis of gastrointestinal neuromuscular disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue SUPPL. 2, 2007, Pages

  Knowles, Charles H ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Chronic intestinal pseudoobstruction; Hirschsprung disease; MEN 2B; Mitochondriopathies; Secondary neuromuscular disorders

Indexed keywords

AGING; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONFERENCE PAPER; CONSTIPATION; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ESOPHAGUS ACHALASIA; GASTROINTESTINAL DISEASE; GENOTYPE; HIRSCHSPRUNG DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNE DYSREGULATION; IRRITABLE COLON; MEGACOLON; NERVE CELL PLASTICITY; NEUROMUSCULAR DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOOBSTRUCTION; TISSUE REPAIR;

AGING; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; NEUROMUSCULAR DISEASES;

EID: 38149100968     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31812e6569     Document Type: Conference Paper

References (66)

1. Drossmann DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45 (Suppl 2):II1-5.
2. Wingate D, Hongo M, Kellow J, et al. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002;17:S1-14.
3. Knowles CH, Silk DBA, Darzi A, et al. Deranged smooth muscle alpha-actin: a biomarker of intestinal pseudo-obstruction. A controlled multinational case series. Gut 2004;53:1583-9.
4. Smith VV, Lake BD, Kamm MA, et al. Intestinal pseudo-obstruction with deficient smooth muscle alpha-actin. Histopathology 1992;21:535-42.
5. Ruuska TH, Karikoski R, Smith VV, et al. Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 2002;122:1133-9.
6. Hassler WL. Is constipation caused by a loss of interstitial cells of Cajal? Gastroenterology 2003;125:264-5.
7. Sanders KM, Koh SD, Ward SM. Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 2006;68:307-43.
8. Won K-J, Suzuki T, Hori M, et al. Motility disorder in experimentally obstructed intestine: relationship between muscularis inflammation and disruption of the ICC network. Neurogastroenterol Motil 2006;18:53-61.
9. Lang B, Vincent A. Autoantibodies to ion channels at the neuromuscular junction. Autoimmun Rev 2002;2:94-100.
10. Delvaux M. Functional bowel disorders and irritable bowel syndrome in Europe. Aliment Pharmacol Ther 2003;18 (Suppl 3):75-9.
11. Burns AJ. Migration of neural crest-derived enteric nervous system precursor cells to and within the gastrointestinal tract. Int J Dev Biol 2005;49:143-50.
12. Gershon MD, Radcliffe EM. Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital abnormalities. Semin Pediatr Surg 2004;13:224-35.
13. Howe DG, Clarke CM, Yan H, et al. Inhibition of protein kinase A in murine enteric neurons causes lethal intestinal pseudo-obstruction. J Neurobiol 2006;66:256-72.
14. Taketomi T, Yoshiga D, Taniguchi K, et al. Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and oesophageal achalasia. Nat Neurosci 2005;8:855-7.
15. de Graaff E, Srinivas S, Kilkenny C, et al. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev 2001;15:2433-44.
16. Fiorica-Howells E, Liu M-T, Ponimaskin EG, et al. Distribution of 5-HT4 receptors in wild-type and analyses of intestinal motility in 5-HT4 knockout mice [abstract]. Gastroenterology 2003;124:A342.
17. Chen JJ, Zhishan L, Pan H, et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001;21:6348-61.
18. Edery P, Lyonnet S, Mulligan LM, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 1994;367:378-80.
19. Angrist M, Bolk S, Thiel B, et al. Mutation of the endothelin receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995;4:2407-9.
20. Hofstra RM, Osinga J, Sindhunata GT, et al. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype. Nature Genet 1996;12:445-7.
21. Auricchio A, Brancolini V, Casari G, et al. The locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28. Am J Hum Genet 1996;58:743-8.
22. Pingault V, Girard M, Bondurand N, et al. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiological mechanism. Hum Genet 2002;111:198-206.
23. Verma A, Piccoli DA, Bonilla E, et al. A novel mitochondrial G8313A mutation associated with initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 1997;42:448-54.
24. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;45:143-6.
25. Knowles CH, Gayther SA, Scott M, et al. Idiopathic slow-transit constipation is not associated with mutations of the RET protooncogene or GDNF. Dis Colon Rectum 2000;43:851-7.
26. Chen B, Knowles CH, Scott M, et al. Idiopathic slow transit constipation and megacolon are not associated with neurturin mutations. Neurogastroenterol Motil 2002;14:513-7.
27. Camilleri CE, Carlson PJ, Camilleri M, et al. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol 2006;101:1-12.
28. Wade PR, Cowen T. Neurodegeneration: a key factor in the ageing gut. Neurogastroenterol Motil 2004;16:19-23.
29. Cowen T, Johnson RJR, Soubeyre V, Santer RM. Restricted diet rescues rat enteric motor neurons from age related cell death. Gut 2000;47:653-60.
30. Galligan JJ, Furness JB, Costa M. Migration of myoelectric complex after interruption of the myenteric plexus: intestinal transaction and regeneration of enteric nerves in the guinea pig. Gastroenterology 1989;97:1135-46.
31. Luck MS, Dahl JL, Botenson MG, et al. Neuroplasticity in the smooth muscle of the myenterically and extrinsically denervated rat jejunum. Cell Tissue Res 1993;271:363-74.
32. Wester T, O'Brian DS, Puri P. Notable postnatal alterations in the myenteric plexus of normal human bowel. Gut 1999;44:666-74.
33. Belai A, Wheeler H, Burnstock G. Innervation of the rat gastrointestinal sphincters: changes during development and ageing. Int J Dev Neurosci 1995;13:81-95.
34. Cowen T, Gavazzi I. Plasticity in adult and ageing sympathetic neurones. Prog Neurobiol 1998;13:81-95.
35. Giaroni C, de Ponti F, Cosentino M, et al. Plasticity in the enteric nervous system. Gastroenterology 1999;117:1438-58.
36. Coulie B, Szarka LA, Camilleri M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000;119:41-50.
37. Knowles CH, Martin J. Slow transit constipation: a model of human gut dysmotility. Review of possible aetiologies. Neurogastroenterol Motil 2000;12:181-96.
38. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-99.
39. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
40. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
41. Tornblom H, Lindberg G, Nyberg B, et al. Full thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9.
42. Higgins LM, Frankel G, Douce G, et al. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to murine inflammatory bowel disease. Infect Immun 1999;67:3031-9.
43. O'Hara JR, Skinn AC, MacNaughton WK, et al. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006;8:646-60.
44. Tache Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004;16 (Suppl 1):137-42.
45. Tache Y, Million M, Nelson AG, et al. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med 2005;2:146-54.
46. Knowles CH, Scott SM, Rayner C, et al. Idiopathic slow-transit constipation: an almost exclusively female disorder. Dis Colon Rectum 2003;46:1716-7.
47. Vincent A. Measuring and evaluating the significance of autoantibodies in neurological disorders. Clin App Immunol 2002;3:127-51.
48. Lennon VA, Sas DF, Bush MF, et al. Enteric neuronal autoantibodies in pseudo-obstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137-42.
49. Howe S, Eaker EY, Sallustio JE, et al. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994;94:761-70.
50. Wood JN, Hudson L, Jessell TM, Yamamoto M. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature 1982;296:34-8.
51. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003;52:629-36.
52. Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997;112:1366-71.
53. Goin JC, Sterin-Borda L, Bilder CR, et al. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. Gastroenterology 1999;117:798-805.
54. Sterin-Borda L, Goin JC, Bilder CR, et al. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 2001;49:699-705.
55. Goldblatt F, Gordon TP, Waterman S. Antibody mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002;123:1144-50.
56. Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-55.
57. Knowles CH, Lang B, Clover L, et al. A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand J Gastroenterol 2002;37:166-70.
58. Bruley des Varannes S, Chevalier J, et al. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 2006;55:319-26.
59. Debinski HS, Kamm MA, Talbot IC, et al. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudoobstruction. Br J Surg 1997;41:100-6.
60. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993;34:299-302.
61. Birgisson S, Galinski MS, Goldblum JR, et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997;42:300-6.
62. Gattuso JM, Debinski HS, Kangro HO, et al. Evaluation of specific herpes DNA viruses in idiopathic megarectum and idiopathic megacolon. Int J Colorectal Dis 1998;13:131-3.
63. MacDonald T, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-5.
64. Haller D. Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol Motil 2006;18:184-99.
65. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
66. Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005;100:1134-42.